evertex fabrinology limited (TPE:1470)
Taiwan · Delayed Price · Currency is TWD 22.55
+0.30 (1.35%)
May 8, 2026, 1:30 PM CST
TPE:1470 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 67.27 | 97.31 | 49.35 | 32.84 | 65.2 |
Depreciation & Amortization | 46.62 | 50.47 | 50.26 | 52.54 | 55.82 |
Other Amortization | 0.07 | 0.08 | 0.1 | 0.14 | 0.13 |
Loss (Gain) From Sale of Assets | -0.01 | -0.52 | -1.09 | - | -1.14 |
Asset Writedown & Restructuring Costs | - | - | - | 0.8 | -1.59 |
Loss (Gain) From Sale of Investments | -0.41 | -0.33 | -13.73 | 41.11 | 1.22 |
Provision & Write-off of Bad Debts | 0.14 | 0.42 | -0.15 | 0.01 | -0.03 |
Other Operating Activities | -15.2 | -10.7 | -14.61 | -4.93 | 6.44 |
Change in Accounts Receivable | -3.41 | -13.02 | 1.01 | 33.93 | -2.28 |
Change in Inventory | 27.99 | -22.78 | 55.42 | 64.26 | -95.7 |
Change in Accounts Payable | -4.62 | 0.41 | -2.74 | -20.05 | -0.01 |
Change in Unearned Revenue | -1.9 | 0.34 | -0.18 | 1.86 | 4.31 |
Change in Other Net Operating Assets | -15.34 | 9.68 | 21.11 | -13.34 | 11.46 |
Operating Cash Flow | 101.2 | 111.35 | 144.74 | 189.18 | 43.83 |
Operating Cash Flow Growth | -9.12% | -23.07% | -23.49% | 331.58% | -42.61% |
Capital Expenditures | -39.14 | -26.33 | -34.12 | -26.98 | -45.15 |
Sale of Property, Plant & Equipment | 0.01 | 0.52 | 1.09 | - | 1.14 |
Sale (Purchase) of Intangibles | - | -0.06 | - | -0.04 | - |
Investment in Securities | -38.4 | 68.81 | -57.35 | -39.29 | 74.05 |
Other Investing Activities | 13.41 | -9.28 | 0.19 | 4.35 | 4.45 |
Investing Cash Flow | -64.11 | 33.65 | -90.2 | -61.95 | 34.48 |
Short-Term Debt Repaid | -5 | -5 | - | - | - |
Long-Term Debt Repaid | -3.91 | -4.15 | -3.63 | -3.95 | -3.9 |
Total Debt Repaid | -8.91 | -9.15 | -3.63 | -3.95 | -3.9 |
Net Debt Issued (Repaid) | -8.91 | -9.15 | -3.63 | -3.95 | -3.9 |
Common Dividends Paid | -86.63 | -49.75 | -38.6 | -68.61 | -36.02 |
Other Financing Activities | - | - | - | 0.4 | - |
Financing Cash Flow | -95.54 | -58.89 | -42.22 | -72.17 | -39.92 |
Foreign Exchange Rate Adjustments | 0.08 | 3.12 | -3.91 | -0.42 | -0.55 |
Net Cash Flow | -58.37 | 89.22 | 8.42 | 54.64 | 37.85 |
Free Cash Flow | 62.06 | 85.02 | 110.62 | 162.2 | -1.32 |
Free Cash Flow Growth | -27.01% | -23.14% | -31.80% | - | - |
Free Cash Flow Margin | 7.72% | 10.79% | 16.88% | 19.19% | -0.15% |
Free Cash Flow Per Share | 0.72 | 0.99 | 1.29 | 1.89 | -0.01 |
Cash Interest Paid | 0.83 | 0.99 | 0.88 | 0.55 | 0.48 |
Cash Income Tax Paid | 27.15 | 11.74 | 15.9 | 14.58 | 3.31 |
Levered Free Cash Flow | 55.65 | 56.12 | 102.65 | 141.21 | -25.02 |
Unlevered Free Cash Flow | 56.17 | 56.71 | 103.21 | 141.56 | -24.72 |
Change in Working Capital | 2.73 | -25.37 | 74.62 | 66.66 | -82.23 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.